🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free

    Vivalyx

    The company develops Omnisol, a patented blood-free liquid solution designed to preserve and revitalize donor organs for transplantation. This solution is compatible with multiple preservation methods including static cold storage and machine perfusion, aiming to increase the number and viability of organs available for patients on waiting lists. Their technology serves the medical transplant industry by reducing complication rates and eliminating the need for blood-based perfusates.

    Visit websiteCologne, Germany
    Healthtech
    MedTech
    Biotechnology

    Funding summary

    Total raised
    €13.9M
    Funding rounds
    3

    Investors in Vivalyx

    Investors on record for Vivalyx. Click any investor to view their CAPLINK profile and funding criteria.

    Fundraising for a startup like Vivalyx?

    Explore CAPLINK's investor database of thousands of active VCs and angels.

    Browse investors

    We use cookies to enhance your experience. Read our Privacy Policy